Genomic research has moved beyond the realm of basic science and is now increasingly applied in clinical practice, with research areas and technologies continuing to expand. Recognizing this growing importance and with the aim of realizing genome-based precision medicine, the Catholic Research Institute for Human Genome Polymorphism (IRCGP) was established.

The Institute conducts research on cancer and complex diseases, as well as infection and microbiome studies, utilizing next-generation sequencing and single-cell analysis technologies. In addition, it provides analytical technology support for clinical applications, facilitates drug candidate discovery, and offers professional training programs in precision medicine.

The Institute also opens its research infrastructure and expertise to genome researchers across Korea, fostering broad collaboration. Moving forward, it is committed to cultivating experts in genomics and bioinformatics, advancing artificial intelligence research in line with the Fourth Industrial Revolution, and developing ultra-precision genomic technologies to overcome the limitations of current therapies—ultimately driving innovation in the future of medicine. We kindly ask for your continued interest and active participation.